Figure 4

Simulated lumefantrine pharmacokinetic parameters at different dosage scenarios for HIV-malaria-co-infected- patients on efavirenz-based treatment. The box and whiskers represent 95% confidence interval of the mean and the first and third quartiles of the simulated.